nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—CYP1A2—chronic obstructive pulmonary disease	0.394	1	CbGaD
Levofloxacin—SLC22A4—Tiotropium—chronic obstructive pulmonary disease	0.229	0.572	CbGbCtD
Levofloxacin—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0358	0.0895	CbGbCtD
Levofloxacin—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0291	0.0728	CbGbCtD
Levofloxacin—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0196	0.0492	CbGbCtD
Levofloxacin—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0187	0.0469	CbGbCtD
Levofloxacin—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0167	0.0418	CbGbCtD
Levofloxacin—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0164	0.041	CbGbCtD
Levofloxacin—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0154	0.0387	CbGbCtD
Levofloxacin—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0098	0.0245	CbGbCtD
Levofloxacin—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00925	0.0232	CbGbCtD
Levofloxacin—TOP2A—Salmeterol—Salbutamol—chronic obstructive pulmonary disease	0.00175	0.807	CbGdCrCtD
Levofloxacin—Pefloxacin—CYP1A2—chronic obstructive pulmonary disease	0.000723	0.179	CrCbGaD
Levofloxacin—Enoxacin—CYP1A2—chronic obstructive pulmonary disease	0.000676	0.167	CrCbGaD
Levofloxacin—Gatifloxacin—ALB—chronic obstructive pulmonary disease	0.000551	0.136	CrCbGaD
Levofloxacin—Lomefloxacin—CYP1A2—chronic obstructive pulmonary disease	0.000512	0.127	CrCbGaD
Levofloxacin—CYP1A2—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.000454	0.0722	CbGpPWpGaD
Levofloxacin—Ofloxacin—CYP1A2—chronic obstructive pulmonary disease	0.000438	0.108	CrCbGaD
Levofloxacin—Ciprofloxacin—CYP1A2—chronic obstructive pulmonary disease	0.000423	0.105	CrCbGaD
Levofloxacin—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000396	0.063	CbGpPWpGaD
Levofloxacin—Norfloxacin—CYP1A1—chronic obstructive pulmonary disease	0.000368	0.091	CrCbGaD
Levofloxacin—Norfloxacin—CYP1A2—chronic obstructive pulmonary disease	0.000355	0.0878	CrCbGaD
Levofloxacin—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00035	0.0557	CbGpPWpGaD
Levofloxacin—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000286	0.0456	CbGpPWpGaD
Levofloxacin—TOP2A—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.000211	0.0975	CbGdCrCtD
Levofloxacin—TOP2A—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.0952	CbGdCrCtD
Levofloxacin—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000145	0.0231	CbGpPWpGaD
Levofloxacin—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000144	0.023	CbGpPWpGaD
Levofloxacin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000123	0.0196	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000115	0.0183	CbGpPWpGaD
Levofloxacin—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000588	CcSEcCtD
Levofloxacin—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000587	CcSEcCtD
Levofloxacin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000113	0.000583	CcSEcCtD
Levofloxacin—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000581	CcSEcCtD
Levofloxacin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000579	CcSEcCtD
Levofloxacin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000579	CcSEcCtD
Levofloxacin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.0178	CbGpPWpGaD
Levofloxacin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000575	CcSEcCtD
Levofloxacin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000111	0.0177	CbGpPWpGaD
Levofloxacin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.000573	CcSEcCtD
Levofloxacin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000111	0.000573	CcSEcCtD
Levofloxacin—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000573	CcSEcCtD
Levofloxacin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000111	0.00057	CcSEcCtD
Levofloxacin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.00057	CcSEcCtD
Levofloxacin—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000569	CcSEcCtD
Levofloxacin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000568	CcSEcCtD
Levofloxacin—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000567	CcSEcCtD
Levofloxacin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000565	CcSEcCtD
Levofloxacin—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000565	CcSEcCtD
Levofloxacin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.000562	CcSEcCtD
Levofloxacin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000109	0.00056	CcSEcCtD
Levofloxacin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00056	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000108	0.000559	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.000559	CcSEcCtD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000108	0.0172	CbGpPWpGaD
Levofloxacin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.000555	CcSEcCtD
Levofloxacin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000108	0.000555	CcSEcCtD
Levofloxacin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000552	CcSEcCtD
Levofloxacin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000107	0.000551	CcSEcCtD
Levofloxacin—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000549	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000106	0.000547	CcSEcCtD
Levofloxacin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000106	0.000547	CcSEcCtD
Levofloxacin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.000547	CcSEcCtD
Levofloxacin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000106	0.000545	CcSEcCtD
Levofloxacin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.000545	CcSEcCtD
Levofloxacin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000105	0.000543	CcSEcCtD
Levofloxacin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000541	CcSEcCtD
Levofloxacin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000105	0.00054	CcSEcCtD
Levofloxacin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.00054	CcSEcCtD
Levofloxacin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000105	0.000539	CcSEcCtD
Levofloxacin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000104	0.000538	CcSEcCtD
Levofloxacin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000104	0.000534	CcSEcCtD
Levofloxacin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000103	0.000533	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.000529	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000103	0.000529	CcSEcCtD
Levofloxacin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000103	0.000529	CcSEcCtD
Levofloxacin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000103	0.000529	CcSEcCtD
Levofloxacin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.000529	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.000528	CcSEcCtD
Levofloxacin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000524	CcSEcCtD
Levofloxacin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000524	CcSEcCtD
Levofloxacin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000524	CcSEcCtD
Levofloxacin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000524	CcSEcCtD
Levofloxacin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.000524	CcSEcCtD
Levofloxacin—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000523	CcSEcCtD
Levofloxacin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.00052	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000101	0.000519	CcSEcCtD
Levofloxacin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000101	0.000518	CcSEcCtD
Levofloxacin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.0001	0.000516	CcSEcCtD
Levofloxacin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.0001	0.000515	CcSEcCtD
Levofloxacin—Pain—Montelukast—chronic obstructive pulmonary disease	9.97e-05	0.000514	CcSEcCtD
Levofloxacin—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	9.97e-05	0.000513	CcSEcCtD
Levofloxacin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	9.95e-05	0.000512	CcSEcCtD
Levofloxacin—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	9.91e-05	0.00051	CcSEcCtD
Levofloxacin—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	9.91e-05	0.00051	CcSEcCtD
Levofloxacin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	9.9e-05	0.00051	CcSEcCtD
Levofloxacin—Purpura—Prednisone—chronic obstructive pulmonary disease	9.89e-05	0.000509	CcSEcCtD
Levofloxacin—Rash—Aminophylline—chronic obstructive pulmonary disease	9.87e-05	0.000508	CcSEcCtD
Levofloxacin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	9.86e-05	0.000508	CcSEcCtD
Levofloxacin—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	9.83e-05	0.000506	CcSEcCtD
Levofloxacin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	9.81e-05	0.000505	CcSEcCtD
Levofloxacin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	9.81e-05	0.000505	CcSEcCtD
Levofloxacin—Headache—Aminophylline—chronic obstructive pulmonary disease	9.8e-05	0.000505	CcSEcCtD
Levofloxacin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	9.77e-05	0.000503	CcSEcCtD
Levofloxacin—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	9.77e-05	0.000503	CcSEcCtD
Levofloxacin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	9.76e-05	0.000503	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	9.74e-05	0.000501	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	9.74e-05	0.000501	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	9.71e-05	0.0005	CcSEcCtD
Levofloxacin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	9.69e-05	0.000499	CcSEcCtD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	9.62e-05	0.0153	CbGpPWpGaD
Levofloxacin—Constipation—Salbutamol—chronic obstructive pulmonary disease	9.62e-05	0.000495	CcSEcCtD
Levofloxacin—Pain—Salbutamol—chronic obstructive pulmonary disease	9.62e-05	0.000495	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	9.54e-05	0.000491	CcSEcCtD
Levofloxacin—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	9.54e-05	0.000491	CcSEcCtD
Levofloxacin—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	9.54e-05	0.000491	CcSEcCtD
Levofloxacin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	9.46e-05	0.000487	CcSEcCtD
Levofloxacin—Urticaria—Formoterol—chronic obstructive pulmonary disease	9.46e-05	0.000487	CcSEcCtD
Levofloxacin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	9.41e-05	0.000485	CcSEcCtD
Levofloxacin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	9.41e-05	0.000485	CcSEcCtD
Levofloxacin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	9.41e-05	0.000485	CcSEcCtD
Levofloxacin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	9.41e-05	0.000485	CcSEcCtD
Levofloxacin—Affect lability—Prednisone—chronic obstructive pulmonary disease	9.39e-05	0.000483	CcSEcCtD
Levofloxacin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	9.38e-05	0.000483	CcSEcCtD
Levofloxacin—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	9.31e-05	0.00048	CcSEcCtD
Levofloxacin—Rash—Tiotropium—chronic obstructive pulmonary disease	9.3e-05	0.000479	CcSEcCtD
Levofloxacin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	9.3e-05	0.000479	CcSEcCtD
Levofloxacin—Nausea—Aminophylline—chronic obstructive pulmonary disease	9.29e-05	0.000479	CcSEcCtD
Levofloxacin—Urticaria—Montelukast—chronic obstructive pulmonary disease	9.27e-05	0.000477	CcSEcCtD
Levofloxacin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	9.27e-05	0.000477	CcSEcCtD
Levofloxacin—Headache—Tiotropium—chronic obstructive pulmonary disease	9.24e-05	0.000476	CcSEcCtD
Levofloxacin—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	9.24e-05	0.000476	CcSEcCtD
Levofloxacin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	9.22e-05	0.000475	CcSEcCtD
Levofloxacin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	9.22e-05	0.000475	CcSEcCtD
Levofloxacin—Face oedema—Prednisone—chronic obstructive pulmonary disease	9.21e-05	0.000474	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	9.19e-05	0.000474	CcSEcCtD
Levofloxacin—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	9.12e-05	0.00047	CcSEcCtD
Levofloxacin—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	9.08e-05	0.000467	CcSEcCtD
Levofloxacin—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	9.07e-05	0.000467	CcSEcCtD
Levofloxacin—Mood swings—Prednisone—chronic obstructive pulmonary disease	9.03e-05	0.000465	CcSEcCtD
Levofloxacin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	8.93e-05	0.00046	CcSEcCtD
Levofloxacin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	8.89e-05	0.000458	CcSEcCtD
Levofloxacin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	8.89e-05	0.000458	CcSEcCtD
Levofloxacin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	8.77e-05	0.000452	CcSEcCtD
Levofloxacin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	8.77e-05	0.000452	CcSEcCtD
Levofloxacin—Nausea—Tiotropium—chronic obstructive pulmonary disease	8.76e-05	0.000451	CcSEcCtD
Levofloxacin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	8.75e-05	0.000451	CcSEcCtD
Levofloxacin—Dry skin—Prednisone—chronic obstructive pulmonary disease	8.74e-05	0.00045	CcSEcCtD
Levofloxacin—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	8.68e-05	0.000447	CcSEcCtD
Levofloxacin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	8.64e-05	0.0138	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	8.59e-05	0.000443	CcSEcCtD
Levofloxacin—Asthenia—Formoterol—chronic obstructive pulmonary disease	8.54e-05	0.00044	CcSEcCtD
Levofloxacin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	8.54e-05	0.00044	CcSEcCtD
Levofloxacin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	8.43e-05	0.000434	CcSEcCtD
Levofloxacin—Pruritus—Formoterol—chronic obstructive pulmonary disease	8.43e-05	0.000434	CcSEcCtD
Levofloxacin—Asthenia—Montelukast—chronic obstructive pulmonary disease	8.37e-05	0.000431	CcSEcCtD
Levofloxacin—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	8.34e-05	0.0133	CbGpPWpGaD
Levofloxacin—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	8.3e-05	0.000427	CcSEcCtD
Levofloxacin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	8.28e-05	0.000427	CcSEcCtD
Levofloxacin—Pruritus—Montelukast—chronic obstructive pulmonary disease	8.25e-05	0.000425	CcSEcCtD
Levofloxacin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	8.15e-05	0.00042	CcSEcCtD
Levofloxacin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	8.15e-05	0.00042	CcSEcCtD
Levofloxacin—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	8.11e-05	0.000418	CcSEcCtD
Levofloxacin—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	8.08e-05	0.000416	CcSEcCtD
Levofloxacin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	8.07e-05	0.000415	CcSEcCtD
Levofloxacin—Sweating increased—Prednisone—chronic obstructive pulmonary disease	8.03e-05	0.000413	CcSEcCtD
Levofloxacin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	7.98e-05	0.000411	CcSEcCtD
Levofloxacin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	7.96e-05	0.00041	CcSEcCtD
Levofloxacin—Erythema—Prednisolone—chronic obstructive pulmonary disease	7.9e-05	0.000407	CcSEcCtD
Levofloxacin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	7.87e-05	0.000406	CcSEcCtD
Levofloxacin—Dizziness—Formoterol—chronic obstructive pulmonary disease	7.87e-05	0.000406	CcSEcCtD
Levofloxacin—Dizziness—Montelukast—chronic obstructive pulmonary disease	7.71e-05	0.000397	CcSEcCtD
Levofloxacin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	7.71e-05	0.000397	CcSEcCtD
Levofloxacin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	7.69e-05	0.000396	CcSEcCtD
Levofloxacin—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	7.59e-05	0.000391	CcSEcCtD
Levofloxacin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	7.57e-05	0.00039	CcSEcCtD
Levofloxacin—Vomiting—Formoterol—chronic obstructive pulmonary disease	7.57e-05	0.00039	CcSEcCtD
Levofloxacin—Rash—Formoterol—chronic obstructive pulmonary disease	7.51e-05	0.000387	CcSEcCtD
Levofloxacin—Rash—Arformoterol—chronic obstructive pulmonary disease	7.51e-05	0.000387	CcSEcCtD
Levofloxacin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	7.51e-05	0.0119	CbGpPWpGaD
Levofloxacin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	7.5e-05	0.000386	CcSEcCtD
Levofloxacin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	7.5e-05	0.000386	CcSEcCtD
Levofloxacin—Headache—Arformoterol—chronic obstructive pulmonary disease	7.46e-05	0.000384	CcSEcCtD
Levofloxacin—Headache—Formoterol—chronic obstructive pulmonary disease	7.46e-05	0.000384	CcSEcCtD
Levofloxacin—Weight decreased—Prednisone—chronic obstructive pulmonary disease	7.46e-05	0.000384	CcSEcCtD
Levofloxacin—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	7.45e-05	0.000384	CcSEcCtD
Levofloxacin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	7.44e-05	0.000383	CcSEcCtD
Levofloxacin—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	7.43e-05	0.000383	CcSEcCtD
Levofloxacin—Vomiting—Montelukast—chronic obstructive pulmonary disease	7.42e-05	0.000382	CcSEcCtD
Levofloxacin—Rash—Montelukast—chronic obstructive pulmonary disease	7.35e-05	0.000379	CcSEcCtD
Levofloxacin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	7.35e-05	0.000378	CcSEcCtD
Levofloxacin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	7.33e-05	0.000378	CcSEcCtD
Levofloxacin—Headache—Montelukast—chronic obstructive pulmonary disease	7.31e-05	0.000376	CcSEcCtD
Levofloxacin—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	7.24e-05	0.000373	CcSEcCtD
Levofloxacin—Angioedema—Prednisolone—chronic obstructive pulmonary disease	7.22e-05	0.000372	CcSEcCtD
Levofloxacin—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	7.2e-05	0.000371	CcSEcCtD
Levofloxacin—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	7.2e-05	0.000371	CcSEcCtD
Levofloxacin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	7.15e-05	0.000368	CcSEcCtD
Levofloxacin—Malaise—Prednisolone—chronic obstructive pulmonary disease	7.13e-05	0.000367	CcSEcCtD
Levofloxacin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	7.1e-05	0.000366	CcSEcCtD
Levofloxacin—Rash—Salbutamol—chronic obstructive pulmonary disease	7.09e-05	0.000365	CcSEcCtD
Levofloxacin—Syncope—Prednisolone—chronic obstructive pulmonary disease	7.09e-05	0.000365	CcSEcCtD
Levofloxacin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	7.08e-05	0.000365	CcSEcCtD
Levofloxacin—Nausea—Formoterol—chronic obstructive pulmonary disease	7.07e-05	0.000364	CcSEcCtD
Levofloxacin—Nausea—Arformoterol—chronic obstructive pulmonary disease	7.07e-05	0.000364	CcSEcCtD
Levofloxacin—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	7.07e-05	0.0112	CbGpPWpGaD
Levofloxacin—Headache—Salbutamol—chronic obstructive pulmonary disease	7.04e-05	0.000363	CcSEcCtD
Levofloxacin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	6.95e-05	0.000358	CcSEcCtD
Levofloxacin—Nausea—Montelukast—chronic obstructive pulmonary disease	6.93e-05	0.000357	CcSEcCtD
Levofloxacin—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	6.83e-05	0.0109	CbGpPWpGaD
Levofloxacin—Hypertension—Prednisolone—chronic obstructive pulmonary disease	6.82e-05	0.000351	CcSEcCtD
Levofloxacin—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	6.78e-05	0.0108	CbGpPWpGaD
Levofloxacin—Bradycardia—Prednisone—chronic obstructive pulmonary disease	6.72e-05	0.000346	CcSEcCtD
Levofloxacin—Nausea—Salbutamol—chronic obstructive pulmonary disease	6.68e-05	0.000344	CcSEcCtD
Levofloxacin—TOP2A—Gastric Cancer Network 2—EGFR—chronic obstructive pulmonary disease	6.68e-05	0.0106	CbGpPWpGaD
Levofloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	6.67e-05	0.0106	CbGpPWpGaD
Levofloxacin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	6.65e-05	0.000342	CcSEcCtD
Levofloxacin—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	6.63e-05	0.000341	CcSEcCtD
Levofloxacin—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	6.6e-05	0.00034	CcSEcCtD
Levofloxacin—Hallucination—Prednisone—chronic obstructive pulmonary disease	6.56e-05	0.000338	CcSEcCtD
Levofloxacin—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	6.54e-05	0.0104	CbGpPWpGaD
Levofloxacin—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	6.48e-05	0.000334	CcSEcCtD
Levofloxacin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	6.45e-05	0.000332	CcSEcCtD
Levofloxacin—Oedema—Prednisolone—chronic obstructive pulmonary disease	6.45e-05	0.000332	CcSEcCtD
Levofloxacin—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	6.43e-05	0.0102	CbGpPWpGaD
Levofloxacin—Shock—Prednisolone—chronic obstructive pulmonary disease	6.35e-05	0.000327	CcSEcCtD
Levofloxacin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	6.29e-05	0.000324	CcSEcCtD
Levofloxacin—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	6.28e-05	0.00999	CbGpPWpGaD
Levofloxacin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	6.23e-05	0.000321	CcSEcCtD
Levofloxacin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	6.16e-05	0.000317	CcSEcCtD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	6.13e-05	0.00975	CbGpPWpGaD
Levofloxacin—Flushing—Prednisone—chronic obstructive pulmonary disease	6.12e-05	0.000315	CcSEcCtD
Levofloxacin—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	6.04e-05	0.00961	CbGpPWpGaD
Levofloxacin—Angiopathy—Prednisone—chronic obstructive pulmonary disease	5.98e-05	0.000308	CcSEcCtD
Levofloxacin—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	5.96e-05	0.000307	CcSEcCtD
Levofloxacin—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	5.91e-05	0.00941	CbGpPWpGaD
Levofloxacin—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	5.89e-05	0.000303	CcSEcCtD
Levofloxacin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	5.83e-05	0.0003	CcSEcCtD
Levofloxacin—Alopecia—Prednisone—chronic obstructive pulmonary disease	5.83e-05	0.0003	CcSEcCtD
Levofloxacin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	5.79e-05	0.000298	CcSEcCtD
Levofloxacin—Mental disorder—Prednisone—chronic obstructive pulmonary disease	5.78e-05	0.000298	CcSEcCtD
Levofloxacin—Erythema—Prednisone—chronic obstructive pulmonary disease	5.74e-05	0.000296	CcSEcCtD
Levofloxacin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	5.74e-05	0.000296	CcSEcCtD
Levofloxacin—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	5.68e-05	0.00905	CbGpPWpGaD
Levofloxacin—TOP2A—Gastric Cancer Network 2—TP53—chronic obstructive pulmonary disease	5.61e-05	0.00892	CbGpPWpGaD
Levofloxacin—Pain—Prednisolone—chronic obstructive pulmonary disease	5.52e-05	0.000284	CcSEcCtD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	5.46e-05	0.00869	CbGpPWpGaD
Levofloxacin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	5.45e-05	0.00868	CbGpPWpGaD
Levofloxacin—Vision blurred—Prednisone—chronic obstructive pulmonary disease	5.41e-05	0.000279	CcSEcCtD
Levofloxacin—TOP2A—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	5.4e-05	0.0086	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	5.4e-05	0.00859	CbGpPWpGaD
Levofloxacin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	5.33e-05	0.000274	CcSEcCtD
Levofloxacin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	5.31e-05	0.000274	CcSEcCtD
Levofloxacin—Anaemia—Prednisone—chronic obstructive pulmonary disease	5.31e-05	0.000273	CcSEcCtD
Levofloxacin—Agitation—Prednisone—chronic obstructive pulmonary disease	5.28e-05	0.000272	CcSEcCtD
Levofloxacin—Angioedema—Prednisone—chronic obstructive pulmonary disease	5.25e-05	0.00027	CcSEcCtD
Levofloxacin—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	5.24e-05	0.00833	CbGpPWpGaD
Levofloxacin—Malaise—Prednisone—chronic obstructive pulmonary disease	5.18e-05	0.000267	CcSEcCtD
Levofloxacin—Vertigo—Prednisone—chronic obstructive pulmonary disease	5.16e-05	0.000266	CcSEcCtD
Levofloxacin—Syncope—Prednisone—chronic obstructive pulmonary disease	5.15e-05	0.000265	CcSEcCtD
Levofloxacin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	5.12e-05	0.000264	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	5.11e-05	0.00813	CbGpPWpGaD
Levofloxacin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	5.05e-05	0.00026	CcSEcCtD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	4.97e-05	0.00791	CbGpPWpGaD
Levofloxacin—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	4.96e-05	0.0079	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	4.96e-05	0.00789	CbGpPWpGaD
Levofloxacin—Hypertension—Prednisone—chronic obstructive pulmonary disease	4.96e-05	0.000255	CcSEcCtD
Levofloxacin—TOP2A—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	4.94e-05	0.00786	CbGpPWpGaD
Levofloxacin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	4.89e-05	0.000252	CcSEcCtD
Levofloxacin—Myalgia—Prednisone—chronic obstructive pulmonary disease	4.89e-05	0.000252	CcSEcCtD
Levofloxacin—Anxiety—Prednisone—chronic obstructive pulmonary disease	4.87e-05	0.000251	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	4.86e-05	0.00025	CcSEcCtD
Levofloxacin—Discomfort—Prednisone—chronic obstructive pulmonary disease	4.83e-05	0.000249	CcSEcCtD
Levofloxacin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	4.75e-05	0.000245	CcSEcCtD
Levofloxacin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	4.69e-05	0.000241	CcSEcCtD
Levofloxacin—Oedema—Prednisone—chronic obstructive pulmonary disease	4.69e-05	0.000241	CcSEcCtD
Levofloxacin—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	4.69e-05	0.00746	CbGpPWpGaD
Levofloxacin—Infection—Prednisone—chronic obstructive pulmonary disease	4.66e-05	0.00024	CcSEcCtD
Levofloxacin—Shock—Prednisone—chronic obstructive pulmonary disease	4.61e-05	0.000237	CcSEcCtD
Levofloxacin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	4.6e-05	0.000237	CcSEcCtD
Levofloxacin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	4.57e-05	0.000236	CcSEcCtD
Levofloxacin—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	4.56e-05	0.00726	CbGpPWpGaD
Levofloxacin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	4.55e-05	0.000234	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	4.55e-05	0.00724	CbGpPWpGaD
Levofloxacin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	4.53e-05	0.000233	CcSEcCtD
Levofloxacin—Anorexia—Prednisone—chronic obstructive pulmonary disease	4.47e-05	0.00023	CcSEcCtD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	4.4e-05	0.007	CbGpPWpGaD
Levofloxacin—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	4.39e-05	0.00699	CbGpPWpGaD
Levofloxacin—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	4.39e-05	0.00698	CbGpPWpGaD
Levofloxacin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	4.27e-05	0.00022	CcSEcCtD
Levofloxacin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	4.26e-05	0.00022	CcSEcCtD
Levofloxacin—Insomnia—Prednisone—chronic obstructive pulmonary disease	4.24e-05	0.000218	CcSEcCtD
Levofloxacin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	4.21e-05	0.000217	CcSEcCtD
Levofloxacin—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	4.16e-05	0.00662	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	4.13e-05	0.00658	CbGpPWpGaD
Levofloxacin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	4.13e-05	0.000212	CcSEcCtD
Levofloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	4.11e-05	0.00654	CbGpPWpGaD
Levofloxacin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	4.07e-05	0.00021	CcSEcCtD
Levofloxacin—Rash—Prednisolone—chronic obstructive pulmonary disease	4.07e-05	0.000209	CcSEcCtD
Levofloxacin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.06e-05	0.000209	CcSEcCtD
Levofloxacin—Fatigue—Prednisone—chronic obstructive pulmonary disease	4.04e-05	0.000208	CcSEcCtD
Levofloxacin—Headache—Prednisolone—chronic obstructive pulmonary disease	4.04e-05	0.000208	CcSEcCtD
Levofloxacin—Constipation—Prednisone—chronic obstructive pulmonary disease	4.01e-05	0.000206	CcSEcCtD
Levofloxacin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	3.86e-05	0.000199	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	3.83e-05	0.000197	CcSEcCtD
Levofloxacin—Nausea—Prednisolone—chronic obstructive pulmonary disease	3.83e-05	0.000197	CcSEcCtD
Levofloxacin—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	3.83e-05	0.00609	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	3.79e-05	0.00604	CbGpPWpGaD
Levofloxacin—Urticaria—Prednisone—chronic obstructive pulmonary disease	3.72e-05	0.000192	CcSEcCtD
Levofloxacin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	3.7e-05	0.000191	CcSEcCtD
Levofloxacin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	3.7e-05	0.000191	CcSEcCtD
Levofloxacin—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	3.45e-05	0.0055	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	3.45e-05	0.000178	CcSEcCtD
Levofloxacin—SLC22A2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	3.37e-05	0.00536	CbGpPWpGaD
Levofloxacin—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.36e-05	0.000173	CcSEcCtD
Levofloxacin—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.32e-05	0.000171	CcSEcCtD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	3.23e-05	0.00513	CbGpPWpGaD
Levofloxacin—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	3.22e-05	0.00513	CbGpPWpGaD
Levofloxacin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.21e-05	0.000165	CcSEcCtD
Levofloxacin—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.1e-05	0.00016	CcSEcCtD
Levofloxacin—TOP2A—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	3.08e-05	0.0049	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	3.04e-05	0.00484	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	3.04e-05	0.00483	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	3.04e-05	0.00483	CbGpPWpGaD
Levofloxacin—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	3.04e-05	0.00483	CbGpPWpGaD
Levofloxacin—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	2.99e-05	0.00476	CbGpPWpGaD
Levofloxacin—Vomiting—Prednisone—chronic obstructive pulmonary disease	2.98e-05	0.000153	CcSEcCtD
Levofloxacin—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	2.96e-05	0.00471	CbGpPWpGaD
Levofloxacin—Rash—Prednisone—chronic obstructive pulmonary disease	2.95e-05	0.000152	CcSEcCtD
Levofloxacin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	2.95e-05	0.000152	CcSEcCtD
Levofloxacin—Headache—Prednisone—chronic obstructive pulmonary disease	2.94e-05	0.000151	CcSEcCtD
Levofloxacin—TOP2A—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	2.87e-05	0.00457	CbGpPWpGaD
Levofloxacin—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	2.84e-05	0.00452	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	2.79e-05	0.00444	CbGpPWpGaD
Levofloxacin—Nausea—Prednisone—chronic obstructive pulmonary disease	2.78e-05	0.000143	CcSEcCtD
Levofloxacin—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	2.67e-05	0.00424	CbGpPWpGaD
Levofloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	2.61e-05	0.00415	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	2.6e-05	0.00414	CbGpPWpGaD
Levofloxacin—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	2.57e-05	0.00409	CbGpPWpGaD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	2.5e-05	0.00398	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	2.49e-05	0.00396	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	2.47e-05	0.00394	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	2.46e-05	0.00391	CbGpPWpGaD
Levofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	2.45e-05	0.00391	CbGpPWpGaD
Levofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	2.42e-05	0.00386	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	2.42e-05	0.00385	CbGpPWpGaD
Levofloxacin—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	2.34e-05	0.00373	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	2.3e-05	0.00367	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.12e-05	0.00337	CbGpPWpGaD
Levofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	2.11e-05	0.00336	CbGpPWpGaD
Levofloxacin—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	2.07e-05	0.0033	CbGpPWpGaD
Levofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	1.99e-05	0.00317	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.95e-05	0.0031	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	1.94e-05	0.00309	CbGpPWpGaD
Levofloxacin—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	1.91e-05	0.00303	CbGpPWpGaD
Levofloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	1.89e-05	0.00301	CbGpPWpGaD
Levofloxacin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	1.87e-05	0.00298	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	1.75e-05	0.00279	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.73e-05	0.00276	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	1.73e-05	0.00275	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	1.68e-05	0.00267	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.59e-05	0.00253	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.56e-05	0.00248	CbGpPWpGaD
Levofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	1.54e-05	0.00244	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.48e-05	0.00236	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	1.42e-05	0.00226	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	1.42e-05	0.00226	CbGpPWpGaD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	1.42e-05	0.00226	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	1.37e-05	0.00217	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	1.35e-05	0.00215	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	1.34e-05	0.00213	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	1.33e-05	0.00212	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.31e-05	0.00208	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	1.31e-05	0.00208	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.29e-05	0.00206	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	1.28e-05	0.00204	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	1.28e-05	0.00204	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.27e-05	0.00202	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GC—chronic obstructive pulmonary disease	1.26e-05	0.002	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	1.26e-05	0.002	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	1.23e-05	0.00196	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	1.22e-05	0.00194	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	1.22e-05	0.00194	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.21e-05	0.00193	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.2e-05	0.00191	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.2e-05	0.0019	CbGpPWpGaD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	1.18e-05	0.00188	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.17e-05	0.00186	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	1.16e-05	0.00184	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	1.15e-05	0.00183	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	1.12e-05	0.00179	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.11e-05	0.00177	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.11e-05	0.00176	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.1e-05	0.00175	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	1.07e-05	0.0017	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	1.06e-05	0.00169	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.06e-05	0.00168	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.04e-05	0.00166	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1e-05	0.00159	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	9.9e-06	0.00158	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.36e-06	0.00149	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.23e-06	0.00147	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.6e-06	0.00137	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	8.5e-06	0.00135	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.49e-06	0.00135	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.16e-06	0.0013	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.04e-06	0.00128	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.21e-06	0.00115	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.06e-06	0.00112	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	6.86e-06	0.00109	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.86e-06	0.00109	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.78e-06	0.00108	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	6.56e-06	0.00104	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.38e-06	0.00102	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	6.19e-06	0.000985	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.06e-06	0.000965	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.01e-06	0.000957	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.7e-06	0.000908	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.7e-06	0.000908	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—TP53—chronic obstructive pulmonary disease	5.66e-06	0.000902	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.63e-06	0.000896	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	5.48e-06	0.000872	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.47e-06	0.000871	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	5.23e-06	0.000833	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	5.13e-06	0.000817	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.09e-06	0.000811	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.89e-06	0.000778	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.76e-06	0.000757	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.69e-06	0.000747	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.37e-06	0.000696	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.35e-06	0.000692	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.31e-06	0.000686	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	4.23e-06	0.000673	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.14e-06	0.00066	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.06e-06	0.000646	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.93e-06	0.000626	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.75e-06	0.000597	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.71e-06	0.00059	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.38e-06	0.000538	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.29e-06	0.000523	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.12e-06	0.000496	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.99e-06	0.000476	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.96e-06	0.000471	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.82e-06	0.000448	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.76e-06	0.000439	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.7e-06	0.00043	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.69e-06	0.000429	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.6e-06	0.000414	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.56e-06	0.000408	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.39e-06	0.00038	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.31e-06	0.000368	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.28e-06	0.000363	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.26e-06	0.00036	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.08e-06	0.000332	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.07e-06	0.00033	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.05e-06	0.000326	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.92e-06	0.000306	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.91e-06	0.000303	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.81e-06	0.000288	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.6e-06	0.000255	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.58e-06	0.000251	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.54e-06	0.000245	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.47e-06	0.000234	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.47e-06	0.000234	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.39e-06	0.000222	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.23e-06	0.000196	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.18e-06	0.000187	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	9.48e-07	0.000151	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	9.07e-07	0.000144	CbGpPWpGaD
